CompletedNCT03261648ANXURGUpdated Aug 31, 2017

Anxiety of Patient and His Partner During Admission to Emergency Department

An observational study in Anxiety and Emergencies, sponsored by University Hospital, Toulouse. Completed at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-08-31.

Primary conditionAnxiety Disorders(the registry's first term)UnverifiedIs this wrong?The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by University Hospital, Toulouse · Observational

Study type: Observational
Model: Other
Time perspective: Prospective
Enrollment: 200
Ages: 18 Years and older
Sex: All

Study summary

Evaluate and compare the impact of partner's stress in the pain of the patient admitted in the emergency department

Read the detailed description

Admission to an emergency department is a major source of anxiety for the patient. Anxiety plays not only a role in its emotional state but can also have consequences on the taking care of the patient and especially on the analgesic procedure.

Since pain is one of the first causes of emergency admission, patient anxiety should not be overlooked. In the emergency department, patient consults frequently, with his partner . Anxiety can also affect the partner, which may affect the patient. No studies have yet demonstrated this correlation.

This study will evaluate, the anxiety of both parties and show the presence or not of an influence of the partner's anxiety on the patient using a standardized questionnaire, the State-Trait Anxiety Inventory- form Y (STAI-Y).

Conditions studied

Anxiety
Emergencies

Browse trials for

Anxiety Disorders 7,201Registry's first term · unverified
Emergencies 1,328

In context

Anxiety Disorders Unverified

7,201 studies on the registry are indexed under Anxiety Disorders; 1,682 are open to participants now.

This study's enrollment of 200 is above the median of 168 across 977 observational studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

University Hospital, Toulouse is the lead sponsor of 807 studies on the registry; 209 are open to participants now.

Browse University Hospital, Toulouse studies →

Compared within Anxiety Disorders, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

Who can participate

Ages eligible: 18 Years and older
Sexes eligible: All
Accepts healthy volunteers: Yes
Sampling method: Non-probability sample

Study population

people admited in the emergency department and his partner

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Admission to emergency department accompanied by his partner (lives in concubinage with the patient)
Nurse patient's classification score up or equal to 3, 4 or 5
Oral consent given to the inclusion by the patient and the partner
Patient and partner Francophone or with a good understanding of French

Exclusion criteria

Exclusion Criteria:

Patient under a system of legal protection
Non-Communicating Patient and partner
Patient and partner unable to write
Refusal of patient or partner
Admission of the patient with shock treatment corresponding to the nurse patient's classification score 1 and 2

Study design

Observational model: Other
Time perspective: Prospective
Enrollment: 200 participants (actual)
Patient registry: No

Groups and cohorts

hospitalized patient
100 patients will completed the 'State-Trait-Anxiety Inventory (Forme Y) questionnaire Patients will evaluated here pain answering to a pain level scale
Other: State-Trait-Anxiety Inventory (Forme Y) questionnaire · Other: pain level scale
partner of the hospitalized patient
100 partners will completed the State-Trait-Anxiety Inventory (Forme Y) questionnaire
Other: State-Trait-Anxiety Inventory (Forme Y) questionnaire

Interventions

OtherState-Trait-Anxiety Inventory (Forme Y) questionnaire
after admission in the emergency department, patient and his partner will completed STAI Y questionnaire.
Otherpain level scale
as usual caregiver will ask to the patient to evaluated his pain level with a scale of one to ten

What researchers measure

Primary outcomes

Compare the anxiety of the patient with that of his partner
The anxiety will be evaluated by the State-Trait-Anxiety Inventory (Forme Y) questionnaire
Time frame: day 1

Secondary outcomes

Study the link between the patient's and his partner's anxiety
A corelation will be do between the score obtained by the patient and the score obtained by the partner at the STAI-Y questionnaire
Time frame: day 1
Evaluate the link between the patient's anxiety and the patient's pain
The patient's pain will be evaluated orally asking to him to use a scale pain to 0 of 10
Time frame: day 1

Study locations

1 site

University Hospital of Toulouse
Toulouse, 31000, France

Timeline

Tracking since Sep 25, 2026

ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2017 to primary completion in Jul 2017, 1 month.

Of 411 non-industry observational studies under Anxiety Disorders, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 49. This study's 1 month is below that.

Counting every sponsor, half of 439 studies reached it within 19 months; a quarter within 6 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered: Jul 27, 2017
First posted: Aug 25, 2017
StartActual: May 23, 2017
Primary completionActual: Jul 6, 2017
CompletionActual: Jul 6, 2017
Last update: Aug 31, 2017

What these dates mean

Start.: When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.: When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.: When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.: Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.

No changes since tracking began. The registry record was last updated on Aug 31, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗

Registry details

Key details

Study ID: NCT03261648
Lead sponsor: University Hospital, Toulouse
Responsible party: Sponsor
First posted: Aug 25, 2017
Start date: May 23, 2017
Primary completion: Jul 6, 2017
Completion: Jul 6, 2017
Last update: Aug 31, 2017

Study contacts

Vincent BOUNES, MD

principal investigator · University Hospital of Toulouse, Toulouse, France

Oversight

Data monitoring committee: No
FDA-regulated drug: No
FDA-regulated device: No

View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Anxiety Disorders →

Other studies from this sponsor

University Hospital, Toulouse →

Start the discussion